Literature DB >> 22476252

The contribution of systematic reviews to the practice of pediatric nephrology.

Elisabeth Hodson1, Jonathan C Craig.   

Abstract

The key to accurate decision-making is to use the best available evidence. Systematic reviews aim to identify and combine evidence using systematic methods to minimize bias to provide reliable data for patient care. While systematic reviews can address different clinical questions, the methodology is most developed for systematic reviews of randomized controlled trials. Such systematic reviews include all available trial evidence, enhance the precision of the estimates of treatment effects, and identify where evidence is lacking or where sufficient evidence is already available. However the term "systematic review" does not guarantee that a review covers all the available data, that the validity of included studies has been appropriately assessed, or that data have been combined appropriately in meta-analyses. Biases in systematic review include those related to identifying data (publication bias, language bias, selective reporting of outcomes) and those due to the design and conduct of trials (selection bias, performance bias, detection bias, attrition bias). Thus, readers should read a systematic review carefully before accepting its results and conclusions. This review examines the information that can be provided by systematic reviews of randomized controlled trials together with the biases that can potentially jeopardize the results and conclusions.

Entities:  

Mesh:

Year:  2012        PMID: 22476252     DOI: 10.1007/s00467-012-2155-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  31 in total

1.  24 weeks of valganciclovir prophylaxis in children after renal transplantation: a 4-year experience.

Authors:  Andres F Camacho-Gonzalez; Julie Gutman; Leonard C Hymes; Traci Leong; Joseph A Hilinski
Journal:  Transplantation       Date:  2011-01-27       Impact factor: 4.939

2.  Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

Authors:  D Moher; B Pham; A Jones; D J Cook; A R Jadad; M Moher; P Tugwell; T P Klassen
Journal:  Lancet       Date:  1998-08-22       Impact factor: 79.321

Review 3.  Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease.

Authors:  Suetonia C Palmer; Sankar D Navaneethan; Jonathan C Craig; David W Johnson; Marcello Tonelli; Amit X Garg; Fabio Pellegrini; Pietro Ravani; Meg Jardine; Vlado Perkovic; Giusi Graziano; Richard McGee; Antonio Nicolucci; Gianni Tognoni; Giovanni F M Strippoli
Journal:  Ann Intern Med       Date:  2010-06-24       Impact factor: 25.391

4.  Risk of cardiovascular events and rofecoxib: cumulative meta-analysis.

Authors:  Peter Jüni; Linda Nartey; Stephan Reichenbach; Rebekka Sterchi; Paul A Dieppe; Matthias Egger
Journal:  Lancet       Date:  2004 Dec 4-10       Impact factor: 79.321

Review 5.  Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.

Authors:  E M Hodson; P G Barclay; J C Craig; C Jones; K Kable; G F M Strippoli; D Vimalachandra; A C Webster
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

6.  Comparison of protocols and registry entries to published reports for randomised controlled trials.

Authors:  Kerry Dwan; Douglas G Altman; Lynne Cresswell; Michaela Blundell; Carrol L Gamble; Paula R Williamson
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

7.  A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

Authors:  Marc A Pfeffer; Emmanuel A Burdmann; Chao-Yin Chen; Mark E Cooper; Dick de Zeeuw; Kai-Uwe Eckardt; Jan M Feyzi; Peter Ivanovich; Reshma Kewalramani; Andrew S Levey; Eldrin F Lewis; Janet B McGill; John J V McMurray; Patrick Parfrey; Hans-Henrik Parving; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert Toto
Journal:  N Engl J Med       Date:  2009-10-30       Impact factor: 91.245

Review 8.  Non-corticosteroid treatment for nephrotic syndrome in children.

Authors:  E M Hodson; N S Willis; J C Craig
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

Review 9.  Grey literature in meta-analyses of randomized trials of health care interventions.

Authors:  S Hopewell; S McDonald; M Clarke; M Egger
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18

10.  Epidemiology and reporting characteristics of systematic reviews.

Authors:  David Moher; Jennifer Tetzlaff; Andrea C Tricco; Margaret Sampson; Douglas G Altman
Journal:  PLoS Med       Date:  2007-03-27       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.